Common use of Check if Exchange is from Restricted Definitive Note to beneficial interest in a Restricted Global Note Clause in Contracts

Check if Exchange is from Restricted Definitive Note to beneficial interest in a Restricted Global Note. In connection with the Exchange of the Owner’s Restricted Definitive Note for a beneficial interest in the [CHECK ONE] ¨ 144A Global Note, ¨ Regulation S Global Note with an equal principal amount, the Owner hereby certifies (i) the beneficial interest is being acquired for the Owner’s own account without transfer and (ii) such Exchange has been effected in compliance with the transfer restrictions applicable to the Restricted Global Notes and pursuant to and in accordance with the Securities Act, and in compliance with any applicable blue sky securities laws of any state of the United States. Upon consummation of the proposed Exchange in accordance with the terms of the Indenture, the beneficial interest issued will be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the relevant Restricted Global Note and in the Indenture and the Securities Act. This certificate and the statements contained herein are made for your benefit and the benefit of the Company. [Insert Name of Transferor] By: Name: Title: Dated: Acadia Healthcare Company, Inc. 000 Xxxxxxxx Xxxxxx Xxxxx, Xxxxx 000 Xxxxxxxx, Xxxxxxxxx 00000 Attention: Xxxxxxxxxxx Xxxxxx U.S. Bank National Association Global Corporate Trust Services 000 Xxxxxxxx Xxxxxx, Xxxxx 000 Xxxxxxxxx, Xxxxxxxxx 00000 Facsimile No.: (000) 000-0000 Attention: Xxxxx Xxxxx, CCTS Re: 5.625% Senior Notes due 2023 Reference is hereby made to the Indenture, dated as of February 11, 2015 (the “Indenture”), among Acadia Healthcare Company, Inc., a Delaware corporation (the “Company”), as issuer, the Guarantors party thereto and U.S. Bank National Association, as trustee. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture. In connection with our proposed purchase of $ aggregate principal amount of: (a) ¨ a beneficial interest in a Global Note, or (b) ¨ a Definitive Note, we confirm that:

Check if Exchange is from Restricted Definitive Note to beneficial interest in a Restricted Global Note. In connection with the Exchange of the Owner’s Restricted Definitive Note for a beneficial interest in the [CHECK ONE] ¨ £ 144A Global Note, ¨ £ Regulation S Global Note with an equal principal amount, the Owner hereby certifies (i) the beneficial interest is being acquired for the Owner’s own account without transfer and (ii) such Exchange has been effected in compliance with the transfer restrictions applicable to the Restricted Global Notes and pursuant to and in accordance with the Securities Act, and in compliance with any applicable blue sky securities laws of any state of the United States. Upon consummation of the proposed Exchange in accordance with the terms of the Indenture, the beneficial interest issued will be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the relevant Restricted Global Note and in the Indenture and the Securities Act. This certificate and the statements contained herein are made for your benefit and the benefit of the Company. [Insert Name of Transferor] By: Name: Title: Dated: Acadia Healthcare Company, Inc. 000 Xxxxxxxx Xxxxxx Xxxxx, Xxxxx 000 Xxxxxxxx, Xxxxxxxxx 00000 Attention: Xxxxxxxxxxx Xxxxxx U.S. Bank National Association Global Corporate Trust Services 000 Xxxxxxxx Xxxxxx, Xxxxx 000 Xxxxxxxxx, Xxxxxxxxx 00000 Facsimile No.: (000) 000-0000 Attention: Xxxxx Xxxxx, CCTS Re: 5.625% Senior Notes due 2023 Reference is hereby made to the This Supplemental Indenture, dated as of February 11, 2015 [__________] (the this “Supplemental Indenture”), among Acadia Healthcare Company, Inc.[name of Restricted Subsidiary], a Delaware corporation [______________] [corporation][limited liability company] (the “Additional Subsidiary Guarantor”), Constellation Oil Services Holding S.A., a public limited liability company (société anonyme) incorporated under the laws of the Grand Duchy of Luxembourg, having its registered office at 0-00, Xxxxxx xx xx Xxxx, X-0000 Xxxxxxxxxx and registered with the Luxembourg Trade and Companies’ Register under number B163424 (together with its successors and assigns, the “Company”)) and Wilmington Trust, as issuer, the Guarantors party thereto and U.S. Bank National Association, as trustee. Capitalized terms used but not defined herein shall have trustee (the meanings given “Trustee”) under the Indenture referred to them in the Indenture. In connection with our proposed purchase of $ aggregate principal amount of: (a) ¨ a beneficial interest in a Global Note, or (b) ¨ a Definitive Note, we confirm that:below.

Check if Exchange is from Restricted Definitive Note to beneficial interest in a Restricted Global Note. In connection with the Exchange of the Owner’s Restricted Definitive Note for a beneficial interest in the the: [CHECK ONE] ¨ 144A Global Note, ¨ Note or Regulation S Global Note with an equal principal amount, the Owner hereby certifies (i) the beneficial interest is being acquired for the Owner’s own account without transfer and (ii) such Exchange has been effected in compliance with the transfer restrictions applicable to the Restricted Global Notes and pursuant to and in accordance with the Securities Act, and in compliance with any applicable blue sky securities laws of any state State of the United States. Upon consummation of the proposed Exchange in accordance with the terms of the Indenture, the beneficial interest issued will be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the relevant Restricted Global Note and in the Indenture and the Securities Act. This certificate and the statements contained herein are made for your benefit and the benefit of the CompanyIssuers. [Insert Name of TransferorOwner] By: Name: Title: Dated: Acadia Healthcare Company, Inc. 000 Xxxxxxxx Xxxxxx Xxxxx, Xxxxx 000 Xxxxxxxx, Xxxxxxxxx 00000 Attention: Xxxxxxxxxxx Xxxxxx U.S. Bank National Association Global Corporate Trust Services 000 Xxxxxxxx Xxxxxx, Xxxxx 000 Xxxxxxxxx, Xxxxxxxxx 00000 Facsimile No.: Supplemental Indenture (000) 000-0000 Attention: Xxxxx Xxxxx, CCTS Re: 5.625% Senior Notes due 2023 Reference is hereby made to the this “Supplemental Indenture”), dated as of February 11, 2015 among (the “IndentureGuaranteeing Subsidiary”), among Acadia Healthcare a subsidiary of Xxxxxxx Dynamics, L.L.C., a Delaware limited liability company (the “Company”), the Company, Xxxxxxx Dynamics Finance Company, a Delaware corporation (together with the Company, the “Issuers”), Xxxxxxx Dynamics Holdings, Inc., a Delaware corporation (the “CompanyParent”), as issuer, the Guarantors party thereto and U.S. Bank National Association, as trustee. Capitalized terms used but not defined herein shall have trustee under the meanings given Indenture referred to them in below (the Indenture. In connection with our proposed purchase of $ aggregate principal amount of: (a) ¨ a beneficial interest in a Global Note, or (b) ¨ a Definitive Note, we confirm that:“Trustee”).

Check if Exchange is from Restricted Definitive Note to beneficial interest in a Restricted Global Note. In connection with the Exchange of the Owner’s Restricted Definitive Note for a beneficial interest in the [CHECK ONE] ¨ G 144A Global Note, ¨ G Regulation S Global Note with an equal principal amount, the Owner hereby certifies (i) the beneficial interest is being acquired for the Owner’s own account without transfer and (ii) such Exchange has been effected in compliance with the transfer restrictions applicable to the Restricted Global Notes and pursuant to and in accordance with the Securities Act, and in compliance with any applicable blue sky securities laws of any state of the United States. Upon consummation of the proposed Exchange in accordance with the terms of the Indenture, the beneficial interest issued will shall be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the relevant Restricted Global Note and in the Indenture and the Securities Act. This certificate and the statements contained herein are made for your benefit and the benefit of the Company. [Insert Name of Transferor] By: Name: Title: Dated: Acadia Healthcare Company, Inc. 000 Cadmus Communications Corporation 0000 Xxxxxxxx Xxxxxx Xxxxx, Xxxxx 000 Xxxxxxxx, Xxxxxxxxx XX 00000 Attention: Xxxxxxxxxxx Xxxxxx U.S. Bank National Association Global Corporate Trust Services 000 Xxxxxxxx Xxxxxx, Xxxxx 000 Xxxxxxxxx, Xxxxxxxxx 00000 Facsimile No.Facsimile: (000) 000-0000 Attention: Xxxx X. Xxxxx Xxxxx, CCTS CUSIP: Re: 5.6258 3/8 % Senior Subordinated Notes due 2023 2014 Reference is hereby made to the Indenture, dated as of February 11June 15, 2015 2004 (the “Indenture”), among Acadia Healthcare Company, Inc.between Cadmus Communications Corporation, a Delaware Virginia corporation (the “Company”), as issuerthe Subsidiary Guarantors and Wachovia Bank, the Guarantors party thereto and U.S. Bank National Association, as trustee. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture. In connection with our proposed purchase of $ aggregate principal amount at maturity of: (a) ¨ a G beneficial interest in a Global Note, or (b) ¨ G a Definitive Note, we confirm that: 1. We understand that any subsequent transfer of the Notes or any interest therein is subject to certain restrictions and conditions set forth in the Indenture and the undersigned agrees to be bound by, and not to resell, pledge or otherwise transfer the Notes or any interest therein except in compliance with, such restrictions and conditions and the United States Securities Act of 1933, as amended (the “Securities Act”). 2. We understand that the offer and sale of the Notes have not been registered under the Securities Act, and that the Notes and any interest therein may not be offered or sold except as permitted in the following sentence. We agree, on our own behalf and on behalf of any accounts for which we are acting as hereinafter stated, that if we should sell the Notes or any interest therein, we shall do so only (A) to the Company or any subsidiary thereof, (B) in accordance with Rule 144A under the Securities Act to a “qualified institutional buyer” (as defined therein), (C) to an institutional “accredited investor” (as defined below) that, prior to such transfer, furnishes (or has furnished on its behalf by a U.S. broker-dealer) to you and to the Company a signed letter substantially in the form of this letter and an Opinion of Counsel in form reasonably acceptable to the Company to the effect that such transfer is in compliance with the Securities Act, (D) outside the United States in accordance with Rule 904 of Regulation S under the Securities Act, (E) pursuant to the provisions of Rule 144 under the Securities Act or (F) pursuant to an effective registration statement under the Securities Act, and we further agree to provide to any person purchasing the Definitive Note or beneficial interest in a Global Note from us in a transaction meeting the requirements of clauses (A) through (E) of this paragraph a notice advising such purchaser that resales thereof are restricted as stated herein.

Check if Exchange is from Restricted Definitive Note to beneficial interest in a Restricted Global Note. In connection with the Exchange of the Owner’s Restricted Definitive Note for a beneficial interest in the [CHECK ONE] ¨ 144A Global Note, ¨ Regulation S Global Note, ¨ IAI Global Note with an equal principal amount, the Owner hereby certifies (i) the beneficial interest is being acquired for the Owner’s own account without transfer and (ii) such Exchange has been effected in compliance with the transfer restrictions applicable to the Restricted Global Notes and pursuant to and in accordance with the Securities Act, and in compliance with any applicable blue sky securities laws of any state of the United States. Upon consummation of the proposed Exchange in accordance with the terms of the Indenture, the beneficial interest issued will be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the relevant Restricted Global Note and in the Indenture and the Securities Act. This certificate and the statements contained herein are made for your benefit and the benefit of the Company. [Insert Name of Transferor] By: Name: Title: Dated: Acadia Healthcare CompanyBioScrip, Inc. 000 Xxxxxxxx Xxxxxx Xxxxx, Xxxxx 000 100 Xxxxxxxxxx Xxxx Xxxxxxxx, Xxxxxxxxx Xxx Xxxx 00000 Attention: Xxxxxxxxxxx Xxxxxx [________________] U.S. Bank National Association Global Corporate Trust Services 000 Xxxxxxxx Oxx Xxxxxxx Xxxxxx, 0xx Xxxxx 000 XxxxxxxxxXxxxxx, Xxxxxxxxx XX 00000 Facsimile No.: (000) 000-0000 Attention: Xxxxx Xxxxx, CCTS Txxx X. XxXxxxx Re: 5.6258.875% Senior Notes due 2023 2021 Reference is hereby made to the Indenture, dated as of February 11, 2015 2014 (the “Indenture”), among Acadia Healthcare CompanyBioScrip, Inc., a Delaware corporation (the “Company”), as issuer, the Guarantors party thereto and U.S. Bank National Association, as trustee. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture. In connection with our proposed purchase of $ aggregate principal amount of: (a) ¨ a beneficial interest in a Global Note, or (b) ¨ a Definitive Note, we confirm that:

Check if Exchange is from Restricted Definitive Note to beneficial interest in a Restricted Global Note. In connection with the Exchange of the Owner’s Restricted Definitive Note for a beneficial interest in the [CHECK ONE] ¨ ☐ 144A Global Note, ¨ ☐ Regulation S Global Note with an equal principal amount, the Owner hereby certifies (i) the beneficial interest is being acquired for the Owner’s own account without transfer and (ii) such Exchange has been effected in compliance with the transfer restrictions applicable to the Restricted Global Notes and pursuant to and in accordance with the Securities Act, and in compliance with any applicable blue sky securities laws of any state of the United States. Upon consummation of the proposed Exchange in accordance with the terms of the Indenture, the beneficial interest issued will be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the relevant Restricted Global Note and in the Indenture and the Securities Act. This certificate and the statements contained herein are made for your benefit and the benefit of the Company. [Insert Name of Transferor] By: Name: Title: Dated: Acadia Healthcare Company, Inc. 000 Xxxxxxxx Xxxxxx Xxxxx, Xxxxx 000 Xxxxxxxx, Xxxxxxxxx 00000 Attention: Xxxxxxxxxxx Xxxxxx U.S. Bank National Association Global Corporate Trust Services 000 Xxxxxxxx Xxxxxx, Xxxxx 000 Xxxxxxxxx, Xxxxxxxxx 00000 Facsimile No.: (000) 000-0000 Attention: Xxxxx Xxxxx, CCTS Re: 5.625% Senior Notes due 2023 Reference is hereby made to the _____________________ This Supplemental Indenture, dated as of February 11, 2015 [__________] (the this “Supplemental Indenture”), among Acadia Healthcare Company, Inc.[name of Restricted Subsidiary], a Delaware corporation [______________] [corporation][limited liability company] (the “Additional Subsidiary Guarantor”), Constellation Oil Services Holding S.A., a public limited liability company (société anonyme) incorporated under the laws of the Grand Duchy of Luxembourg, having its registered office at 0-00, Xxxxxx xx xx Xxxx, X-0000 Xxxxxxxxxx and registered with the Luxembourg Trade and Companies’ Register under number B163424 (together with its successors and assigns, the “Company”)) and Wilmington Trust, as issuer, the Guarantors party thereto and U.S. Bank National Association, as trustee. Capitalized terms used but not defined herein shall have trustee (the meanings given “Trustee”) under the Indenture referred to them in the Indenture. In connection with our proposed purchase of $ aggregate principal amount of: (a) ¨ a beneficial interest in a Global Note, or (b) ¨ a Definitive Note, we confirm that:below.

Check if Exchange is from Restricted Definitive Note to beneficial interest in a Restricted Global Note. In connection with the Exchange of the Owner’s Restricted Definitive Note for a beneficial interest in the [CHECK ONE] ¨ ☐ 144A Global Note, ¨ ☐ Regulation S Global Note with an equal principal amount, the Owner hereby certifies (i) the beneficial interest is being acquired for the Owner’s own account without transfer and (ii) such Exchange has been effected in compliance with the transfer restrictions applicable to the Restricted Global Notes and pursuant to and in accordance with the Securities Act, and in compliance with any applicable blue sky securities laws of any state of the United States. Upon consummation of the proposed Exchange in accordance with the terms of the Indenture, the beneficial interest issued will be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the relevant Restricted Global Note and in the Indenture and the Securities Act. This certificate and the statements contained herein are made for your benefit and the benefit of the Company. [Insert Name of Transferor] By: Name: Title: Dated: Acadia Healthcare Company, Inc. 000 Xxxxxxxx Xxxxxx Xxxxx, Xxxxx 000 Xxxxxxxx, Xxxxxxxxx 00000 Attention: Xxxxxxxxxxx Xxxxxx U.S. Bank National Association Global Corporate Trust Services 000 Xxxxxxxx Xxxxxx, Xxxxx 000 Xxxxxxxxx, Xxxxxxxxx 00000 Facsimile No.: ______________________ SUPPLEMENTAL INDENTURE (000this “Supplemental Indenture”) 000-0000 Attention: Xxxxx Xxxxx, CCTS Re: 5.625% Senior Notes due 2023 Reference is hereby made to the Indenture, dated as of February 11_________, 2015 among [name of New Subsidiary Guarantor[s]] (the “IndentureNew Subsidiary Guarantor”), among Acadia Healthcare Company, Inc.Studio City Finance Limited, a Delaware corporation BVI business company with limited liability incorporated under the laws of British Virgin Islands (the “Company”)) and Deutsche Bank Trust Company Americas, as issuerTrustee (in such role, the Guarantors party thereto and U.S. Bank National Association, as trustee. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture. In connection with our proposed purchase of $ aggregate principal amount of: (a) ¨ a beneficial interest in a Global Note, or (b) ¨ a Definitive Note, we confirm that:“Trustee”).

Check if Exchange is from Restricted Definitive Note to beneficial interest in a Restricted Global Note. In connection with the Exchange of the Owner’s Restricted Definitive Note for a beneficial interest in the [CHECK ONE] ¨ 144A Global Note, ¨ Regulation S Global Note with an equal principal amount, the Owner hereby certifies (i) the beneficial interest is being acquired for the Owner’s own account without transfer and (ii) such Exchange has been effected in compliance with the transfer restrictions applicable to the Restricted Global Notes and pursuant to and in accordance with the Securities Act, and in compliance with any applicable blue sky securities laws of any state of the United States. Upon consummation of the proposed Exchange in accordance with the terms of the Indenture, the beneficial interest issued will shall be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the relevant Restricted Global Note and in the Indenture and the Securities Act. This certificate and the statements contained herein are made for your benefit and the benefit of the Company. [Insert Name of Transferor] By: Name: Title: Dated: Acadia Healthcare Company, Inc. Xxxxxxxxx Technologies Corporation 000 Xxxxxxxx 000xx Xxxxxx XxxxxXX, Xxxxx 000 0000 Xxxxxxxx, Xxxxxxxxx Xxxxxxxxxx 00000 Attention: Xxxxxxxxxxx Xxxxxx U.S. Bank National Association Global Corporate Trust Services 000 Xxxxxxxx Xxxxxx, Xxxxx 000 Xxxxxxxxx, Xxxxxxxxx 00000 Facsimile No.Facsimile: (000) 000-0000 Attention: Xxxxx Xxxxx, CCTS Xxxxxx X. Xxxxxx CUSIP: Re: 5.6257% Senior Notes due 2023 2020 Reference is hereby made to the Indenture, dated as of February 11August 2, 2015 2010 (the “Indenture”), among Acadia Healthcare Company, Inc.between Xxxxxxxxx Technologies Corporation, a Delaware corporation (the “Company”), as issuerthe Subsidiary Guarantors and Xxxxx Fargo Bank, the Guarantors party thereto and U.S. Bank National Association, as trustee. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture. In connection with our proposed purchase of $ aggregate principal amount at maturity of: (a) ¨ a beneficial interest in a Global Note, or (b) ¨ a Definitive Note, we confirm that: 1. We understand that any subsequent transfer of the Notes or any interest therein is subject to certain restrictions and conditions set forth in the Indenture and the undersigned agrees to be bound by, and not to resell, pledge or otherwise transfer the Notes or any interest therein except in compliance with, such restrictions and conditions and the United States Securities Act of 1933, as amended (the “Securities Act”). 2. We understand that the offer and sale of the Notes have not been registered under the Securities Act, and that the Notes and any interest therein may not be offered or sold except as permitted in the following sentence. We agree, on our own behalf and on behalf of any accounts for which we are acting as hereinafter stated, that if we should sell the Notes or any interest therein, we shall do so only (A) to the Company or any subsidiary thereof, (B) in accordance with Rule 144A under the Securities Act to a “qualified institutional buyer” (as defined therein), (C) to an institutional “accredited investor” (as defined below) that, prior to such transfer, furnishes (or has furnished on its behalf by a U.S. broker-dealer) to you and to the Company a signed letter substantially in the form of this letter and an Opinion of Counsel in form reasonably acceptable to the Company to the effect that such transfer is in compliance with the Securities Act, (D) outside the United States in accordance with Rule 904 of Regulation S under the Securities Act, (E) pursuant to the provisions of Rule 144 under the Securities Act or (F) pursuant to an effective registration statement under the Securities Act, and we further agree to provide to any person purchasing the Definitive Note or beneficial interest in a Global Note from us in a transaction meeting the requirements of clauses (A) through (E) of this paragraph a notice advising such purchaser that resales thereof are restricted as stated herein. 3. We understand that, on any proposed resale of the Notes or beneficial interest therein, we shall be required to furnish to you and the Company such certifications, legal opinions and other information as you and the Company may reasonably require to confirm that the proposed sale complies with the foregoing restrictions. We further understand that the Notes purchased by us shall bear a legend to the foregoing effect. 4. We are an institutional “accredited investor” (as defined in Rule 501(a)(1), (2), (3) or (7) of Regulation D under the Securities Act) and have such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of our investment in the Notes, and we and any accounts for which we are acting are each able to bear the economic risk of our or its investment. 5. We are acquiring the Notes or beneficial interest therein purchased by us for our own account or for one or more accounts (each of which is an institutional “accredited investor”) as to each of which we exercise sole investment discretion.

Check if Exchange is from Restricted Definitive Note to beneficial interest in a Restricted Global Note. In connection with the Exchange of the Owner’s Restricted Definitive Note for a beneficial interest in the [CHECK ONE] ¨ ☐ 144A Global Note, ¨ ☐ Regulation S Global Note with an equal principal amount, the Owner hereby certifies (i) the beneficial interest is being acquired for the Owner’s own account without transfer and (ii) such Exchange has been effected in compliance with the transfer restrictions applicable to the Restricted Global Notes and pursuant to and in accordance with the Securities Act, and in compliance with any applicable blue sky securities laws of any state of the United States. Upon consummation of the proposed Exchange in accordance with the terms of the Indenture, the beneficial interest issued will be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the relevant Restricted Global Note and in the Indenture and the Securities Act. This certificate and the statements contained herein are made for your benefit and the benefit of the Company. [Insert Name of Transferor] By: Name: Title: Dated: Acadia Healthcare Company, Inc. 000 Xxxxxxxx Xxxxxx Xxxxx, Xxxxx 000 Xxxxxxxx, Xxxxxxxxx 00000 Attention: Xxxxxxxxxxx Xxxxxx U.S. Bank National Association Global Corporate Trust Services 000 Xxxxxxxx Xxxxxx, Xxxxx 000 Xxxxxxxxx, Xxxxxxxxx 00000 Facsimile No.: (000) 000-0000 Attention: Xxxxx Xxxxx, CCTS Re: 5.625% Senior Notes due 2023 Reference is hereby made to the This Supplemental Indenture, dated as of February 11, 2015 [__________] (the this “Supplemental Indenture”), among Acadia Healthcare Company, Inc.Olinda Star Ltd., a Delaware corporation company limited by shares incorporated under the laws of the British Virgin Islands (the “Additional Subsidiary Guarantor”), Constellation Oil Services Holding S.A., a public limited liability company (société anonyme) incorporated under the laws of the Grand Duchy of Luxembourg, having its registered office at 0-00, Xxxxxx xx xx Xxxx, X-0000 Xxxxxxxxxx and registered with the Luxembourg Trade and Companies’ Register under number B163424 (together with its successors and assigns, the “Company”)) and Wilmington Trust, as issuer, the Guarantors party thereto and U.S. Bank National Association, as trustee. Capitalized terms used but not defined herein shall have trustee (the meanings given “Trustee”) under the Indenture referred to them in the Indenture. In connection with our proposed purchase of $ aggregate principal amount of: (a) ¨ a beneficial interest in a Global Note, or (b) ¨ a Definitive Note, we confirm that:below.

Check if Exchange is from Restricted Definitive Note to beneficial interest in a Restricted Global Note. In connection with the Exchange of the Owner’s 's Restricted Definitive Note for a beneficial interest in the [CHECK ONE] ¨ [ ] 144A Global Note, ¨ [ ] Regulation S Global Note with an equal principal amount, the Owner hereby certifies (i) the beneficial interest is being acquired for the Owner’s 's own account without transfer and (ii) such Exchange has been effected in compliance with the transfer restrictions applicable to the Restricted Global Notes and pursuant to and in accordance with the Securities Act, and in compliance with any applicable blue sky securities laws of any state of the United States. Upon consummation of the proposed Exchange in accordance with the terms of the Indenture, the beneficial interest issued will shall be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the relevant Restricted Global Note and in the Indenture and the Securities Act. This certificate and the statements contained herein are made for your benefit and the benefit of the Company. [Insert Name of Transferor] By: Name: Title: <PAGE> C-2 Dated: Acadia Healthcare Company, Inc. 000 Xxxxxxxx Xxxxxx Xxxxx<PAGE> C-3 Xxxxxxxxx Technologies Corporation 00000 XX 0xx Xxxxxx, Xxxxx 000 Xxxxxxxx, Xxxxxxxxx Xxxxxxxxxx 00000 Attention: Xxxxxxxxxxx Xxxxxx U.S. Bank National Association Global Corporate Trust Services 000 Xxxxxxxx Xxxxxx, Xxxxx 000 Xxxxxxxxx, Xxxxxxxxx 00000 Facsimile No.Facsimile: (000) 000-0000 Attention: Xxxxx Xxxxx, CCTS Xxxxxx X. Xxxxxx CUSIP: ____________ Re: 5.6257.75% Senior Subordinated Notes due 2023 2013 Reference is hereby made to the Indenture, dated as of February June 11, 2015 2003 (the “"Indenture”"), among Acadia Healthcare Company, Inc.between Xxxxxxxxx Technologies Corporation, a Delaware corporation (the “"Company”"), as issuer, the Subsidiary Guarantors party thereto and U.S. The Bank National Associationof New York, as trustee. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture. In connection with our proposed purchase of $ $____________ aggregate principal amount at maturity of: (a) ¨ a beneficial interest in a Global Note, or (b) ¨ a Definitive Note, we confirm that:

Check if Exchange is from Restricted Definitive Note to beneficial interest in a Restricted Global Note. In connection with the Exchange of the Owner’s Restricted Definitive Note for a beneficial interest in the [CHECK ONE] ¨ 144A Global Note, ¨ Regulation S Global Note with an equal principal amount, the Owner hereby certifies (i) the beneficial interest is being acquired for the Owner’s own account without transfer and (ii) such Exchange has been effected in compliance with the transfer restrictions applicable to the Restricted Global Notes and pursuant to and in accordance with the Securities Act, and in compliance with any applicable blue sky securities laws of any state of the United States. Upon consummation of the proposed Exchange in accordance with the terms of the Indenture, the beneficial interest issued will be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the relevant Restricted Global Note and in the Indenture and the Securities Act. This certificate and the statements contained herein are made for your benefit and the benefit of the Company. [Insert Name of Transferor] By: Name: Title: Dated: Acadia Healthcare Company, Inc. 000 Xxxxxxxx Xxxxxx Xxxxx, Xxxxx 000 Xxxxxxxx, Xxxxxxxxx 00000 Attention: Xxxxxxxxxxx Xxxxxx U.S. Bank National Association Global Corporate Trust Services 000 Xxxxxxxx Xxxxxx, Xxxxx 000 Xxxxxxxxx, Xxxxxxxxx 00000 Facsimile No.: (000) 000-0000 Attention: Xxxxx Xxxxx, CCTS Re: 5.6256.125% Senior Notes due 2023 2021 Reference is hereby made to the Indenture, dated as of February 11March 12, 2015 2013 (the “Indenture”), among Acadia Healthcare Company, Inc., a Delaware corporation (the “Company”), as issuer, the Guarantors party thereto and U.S. Bank National Association, as trustee. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture. In connection with our proposed purchase of $ aggregate principal amount of: (a) ¨ a beneficial interest in a Global Note, or (b) ¨ a Definitive Note, we confirm that: